Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Journal of Immunology (Baltimore, Md. : 1950)|February 29, 2000
The IL-2 receptor promotes lymphocyte proliferation and induction of the c-myc, bcl-2, and bcl-x genes through the trans-activation domain of Stat5J D Lord, B C McIntosh, P D Greenberg, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 30, 1998
The IL-2 receptor promotes proliferation, bcl-2 and bcl-x induction, but not cell viability through the adapter molecule ShcJ D Lord, B C McIntosh, P D Greenberg, et al.
Acta Orthopaedica Scandinavica|October 1, 1988
Effect of osteochondral defects on articular cartilage. Contact pressures studied in dog kneesB H Nelson, D D Anderson, R A Brand, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 13, 2001
Stat5 and Sp1 regulate transcription of the cyclin D2 gene in response to IL-2A Martino, J H Holmes, J D Lord, et al.
Immunity|October 8, 1999
Uncoupling IL-2 signals that regulate T cell proliferation, survival, and Fas-mediated activation-induced cell deathL Van Parijs, Y Refaeli, J D Lord, et al.
Gene|April 21, 2001
MAGE-F1, a novel ubiquitously expressed member of the MAGE superfamilyB Stone, M Schummer, P J Paley, et al.
FEBS Letters|February 14, 1998
Homodimerization of IL-2 receptor beta chain is necessary and sufficient to activate Jak2 and downstream signaling pathwaysF Ferrag, A Pezet, A Chiarenza, et al.
Molecular and Cellular Biology|September 13, 2000
New role for Shc in activation of the phosphatidylinositol 3-kinase/Akt pathwayH Gu, H Maeda, J J Moon, et al.
British Journal of Cancer|November 22, 2012
Tumour-infiltrating FOXP3(+) lymphocytes are associated with cytotoxic immune responses and good clinical outcome in oestrogen receptor-negative breast cancerN R West, S E Kost, S D Martin, et al.
The Journal of Biological Chemistry|March 6, 1999
Role of interleukin (IL)-2 receptor beta-chain subdomains and Shc in p38 mitogen-activated protein (MAP) kinase and p54 MAP kinase (stress-activated protein Kinase/c-Jun N-terminal kinase) activation. IL-2-driven proliferation is independent of p38 and p54 MAP kinase activationA E Hunt, F V Lali, J D Lord, et al.
Pageof 3